• Friday, October 14, 2022

Boston Sheraton Hotel

49 Dalton St, Boston, MA 02199

Attend the 2022 ALS TDI Summit

Attend the annual ALS TDI Summit on October 14, 2022, to hear first-hand about the current progress that the ALS Therapy Development Institute (ALS TDI) is making in our research to end ALS.

The ALS TDI Summit is a free annual conference hosted by ALS TDI, the Drug Discovery Engine for ALS. The event aims to inform community members and scientists by providing updates on current ALS research. The Summit includes:

• ● Presentations on ALS TDI’s current research led by members of our science team
• ● Guest presentations from leading experts in ALS research
• ● Presentation of the ALS TDI Leadership Awards to members of the community

How Would You Like to Attend?

This year you have the option to attend the in-person event in Boston or join the event virtually via our live-stream. In-person attendance is limited, so reserve your spot today.

Vaccinations are required for all guests

Register Today

Event Schedule:

10:00 am WELCOME ADDRESS / FUELING THE CLINICAL PIPELINE

Presented by Dr. Fernando Vieira, CEO & Chief Scientific Officer

10:30 am LEVERAGING ANIMAL MODELS TO TREAT ALS

Presented by Dr. Theo Hatzipetros, Director of Pharmacology

11:00 am DISCOVERING ALS DISEASE PHENOTYPES IN CELL MODELS

Presented by Anna Gill, Associate Scientist II, Program Manager

11:15 am TURNING CELL PHENOTYPES INTO SCREENS: FINDING THERAPIES AND TARGETS FOR ALS

Presented by Dr. Kyle Denton, Director, Cell Biology

11:30 am THE PMP: HOW YOUR DATA FUELS OUR RESEARCH

Presented by Alan Premasiri, Manager of Clinical Operations/Associate Scientist II

12:00 pm LUNCH & NETWORKING

1:00 pm NEW INNOVATIONS IN ALS THERAPEUTICS

Presented by Dr. Merit Cudkowicz, Director of the Sean M. Healey & AMG Center for ALS, Chief of Neurology at MGH

1:30 pm THE DEPARTMENT OF DEFENSE (CDMRP) ALS RESEARCH PROGRAM

Presented by Dr. Lyle Ostrow, ALS clinician and scientist, Johns Hopkins University

2:00 pm FROM CONCEPT TO CLINICAL TRIALS AND BEYOND

Presented by Josh Cohen and Justin Klee, Co-CEOs & Co-Founders of Amylyx

2:30 pm TEGOPRUBART (AT-1501) IS SAFE AND WELL TOLERATED AND REDUCES INFLAMMATION IN PATIENTS WITH ALS

Presented by Dr. Steven Perrin, President & Chief Scientific Officer, Eledon Pharmaceuticals

3:15 pm LEADERSHIP AWARDS PRESENTATION

Presented by Carol Hamilton, Vice President of Development, ALS TDI

Additional program details will be available soon.

Who Should Attend the ALS TDI Summit?

The ALS TDI Summit is free and is open to all members of the ALS community, including:

- people with ALS

- caregivers

- friends and family members

- members of the ALS research and science community

We hope you can join us at the Summit to learn more about the progress we are making together.

All of our progress to end ALS is thanks to the support of the ALS community.

Thank you to our sponsors of the ALS TDI Leadership Weekend